Glavine Paul
SEC insider (Form 3/4/5 filer). CIK 0002118509. Chief Growth Officer at Helus Pharma Inc. (HELP). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in TORONTO.
Companies Glavine Paul has filed insider reports for
- Helus Pharma Inc. (HELP): Director, Officer, Chief Growth Officer
Glavine Paul
CIK: 0002118509
Transaction Breakdown
Open Market Buys (P)3 (75.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HELP
Helus Pharma Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 30, 2026HELP
Helus Pharma Inc.
AwardDirect248K shares- - Sep 8, 2026CYBN
CYBIN INC.
PurchaseDirect100K shares at avg. $12.47$1.2M - Sep 3, 2026CYBN
CYBIN INC.
PurchaseDirect100K shares at avg. $11.78$1.2M - Aug 31, 2026CYBN
CYBIN INC.
PurchaseDirect90K shares at avg. $11.59$1.0M
1-4 of 4 transactions